NO990541L - Krystallinsk form av 4-(5-metyl-3-fenylisoksazol-4-yl)benzensulfonamid - Google Patents

Krystallinsk form av 4-(5-metyl-3-fenylisoksazol-4-yl)benzensulfonamid

Info

Publication number
NO990541L
NO990541L NO990541A NO990541A NO990541L NO 990541 L NO990541 L NO 990541L NO 990541 A NO990541 A NO 990541A NO 990541 A NO990541 A NO 990541A NO 990541 L NO990541 L NO 990541L
Authority
NO
Norway
Prior art keywords
phenylisoxazol
benzenesulfonamide
methyl
crystalline form
crystalline
Prior art date
Application number
NO990541A
Other languages
English (en)
Other versions
NO990541D0 (no
NO312461B1 (no
Inventor
John J Talley
John R Medich
Kathleen T Mclaughlin
Henry T Gaud
Edward E Yonan
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of NO990541D0 publication Critical patent/NO990541D0/no
Publication of NO990541L publication Critical patent/NO990541L/no
Publication of NO312461B1 publication Critical patent/NO312461B1/no

Links

Classifications

    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L23/00—Details of semiconductor or other solid state devices
    • H01L23/34—Arrangements for cooling, heating, ventilating or temperature compensation ; Temperature sensing arrangements
    • H01L23/40—Mountings or securing means for detachable cooling or heating arrangements ; fixed by friction, plugs or springs
    • H01L23/4006—Mountings or securing means for detachable cooling or heating arrangements ; fixed by friction, plugs or springs with bolts or screws
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L23/00—Details of semiconductor or other solid state devices
    • H01L23/34—Arrangements for cooling, heating, ventilating or temperature compensation ; Temperature sensing arrangements
    • H01L23/42—Fillings or auxiliary members in containers or encapsulations selected or arranged to facilitate heating or cooling
    • H01L23/427—Cooling by change of state, e.g. use of heat pipes
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L2924/00—Indexing scheme for arrangements or methods for connecting or disconnecting semiconductor or solid-state bodies as covered by H01L24/00
    • H01L2924/0001—Technical content checked by a classifier
    • H01L2924/0002—Not covered by any one of groups H01L24/00, H01L24/00 and H01L2224/00
NO19990541A 1996-08-14 1999-02-05 Krystallinsk form B av 4-[5-metyl-3-fenylisoksazol-4- yl]benzensulfonamid NO312461B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2437896P 1996-08-14 1996-08-14
PCT/US1997/015126 WO1998006708A1 (en) 1996-08-14 1997-08-12 Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide

Publications (3)

Publication Number Publication Date
NO990541D0 NO990541D0 (no) 1999-02-05
NO990541L true NO990541L (no) 1999-02-05
NO312461B1 NO312461B1 (no) 2002-05-13

Family

ID=21820280

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19990541A NO312461B1 (no) 1996-08-14 1999-02-05 Krystallinsk form B av 4-[5-metyl-3-fenylisoksazol-4- yl]benzensulfonamid

Country Status (39)

Country Link
US (2) US6441014B2 (no)
EP (2) EP0920422B1 (no)
JP (2) JP3631763B2 (no)
KR (1) KR100383148B1 (no)
CN (1) CN1205193C (no)
AP (1) AP1055A (no)
AR (1) AR009244A1 (no)
AT (1) ATE228117T1 (no)
AU (1) AU722072B2 (no)
BG (1) BG64259B1 (no)
BR (1) BR9711151A (no)
CA (1) CA2264104A1 (no)
CZ (1) CZ297679B6 (no)
DE (1) DE69717281T2 (no)
DK (1) DK0920422T3 (no)
EA (2) EA001472B1 (no)
EE (1) EE04237B1 (no)
ES (1) ES2188971T3 (no)
GE (1) GEP20022636B (no)
HK (1) HK1023125A1 (no)
HU (1) HUP0400923A3 (no)
IL (2) IL128255A (no)
IS (1) IS1989B (no)
LT (1) LT4551B (no)
LV (1) LV12274B (no)
NO (1) NO312461B1 (no)
NZ (1) NZ334132A (no)
OA (1) OA11298A (no)
PL (1) PL191313B1 (no)
PT (1) PT920422E (no)
RO (1) RO120771B1 (no)
RS (1) RS49671B (no)
SI (1) SI9720059B (no)
SK (1) SK283558B6 (no)
TR (1) TR199900298T2 (no)
TW (1) TW527350B (no)
UA (1) UA52684C2 (no)
WO (1) WO1998006708A1 (no)
ZA (1) ZA977314B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0400923A3 (en) * 1996-08-14 2007-11-28 Searle & Co Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide, process for its preparation, its use and pharmaceutical compositions containing it
NZ333399A (en) * 1997-12-24 2000-05-26 Sankyo Co Cyclooxygenase-2 inhibitors (COX-2) for the prevention and treatment of tumors, cachexia and tumor-metastasis
GB9810920D0 (en) * 1998-05-21 1998-07-22 Merck Sharp & Dohme Therapeutic use
ES2255294T3 (es) * 1998-08-07 2006-06-16 Chiron Corporation Derivados de isoxazol sustituidos como moduladores del receptor de estrogenos.
AU1398899A (en) * 1998-11-12 2000-06-05 Algos Pharmaceutical Corporation Cox-2 inhibitors in combination with centrally acting analgesics
CN1349423A (zh) * 1999-03-01 2002-05-15 奥索-麦克尼尔药品公司 包含曲马多物质和选择性cox－2抑制剂药物的组合物
CZ2002524A3 (cs) * 1999-08-20 2002-11-13 Ortho-Mcneil Pharmaceutical, Inc. Kompozice obsahující tramadol a antikonvulziva
WO2001015687A1 (en) * 1999-08-27 2001-03-08 Merck & Co., Inc. Method for treating or preventing chronic prostatitis or chronic pelvic pain syndrome
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
CA2455050C (en) 2001-08-15 2007-02-20 Pharmacia & Upjohn Company Crystals including a malic acid salt of n-[2-(diethylamino) ethyl]-5-[(5-fluoro-2-oxo-3h-indole-3-ylidene) methyl]-2, 4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof
US20070072921A1 (en) * 2002-07-26 2007-03-29 Talley John J Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl] benzenesulfonamide
US7538126B2 (en) 2003-04-04 2009-05-26 Hetero Drugs Limited Crystalline forms of valdecoxib
JP4354984B2 (ja) 2003-05-07 2009-10-28 オステオロジックス エイ／エス 水溶性ストロンチウム塩を用いる軟骨／骨症状の治療
US20050182113A1 (en) * 2003-12-30 2005-08-18 Venkataraman Sundaram Method for preparing diaryl-substituted isoxazole compounds
US20050272787A1 (en) * 2004-05-19 2005-12-08 Eswaraiah Sajja Process for preparing crystalline form A of valdecoxib
WO2005120499A1 (en) * 2004-06-10 2005-12-22 Chandiran Thakashinamoorthy Form a of valdecoxib suitable for pharmaceutical formulations
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
ES2291780T3 (es) * 2004-06-28 2008-03-01 Grunenthal Gmbh Formas cristalinas del clorhidrato de (-)-(1r,2r)-3-(3-dimetilamino-1-etil-2-metilpropil)fenol.
KR100591786B1 (ko) 2004-10-19 2006-06-26 휴먼팜 주식회사 프란루카스트를 함유하는 약학적 조성물 및 이의 제조 방법
WO2006127184A1 (en) 2005-05-20 2006-11-30 Janssen Pharmaceutica N.V. Process for preparation of sulfamide derivatives
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
AR058389A1 (es) 2005-12-19 2008-01-30 Janssen Pharmaceutica Nv Uso de derivados heterociclicos benzo-fusionados de sulfamida para el tratamiento de la obesidad
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
AU2007253814A1 (en) 2006-05-19 2007-11-29 Janssen Pharmaceutica N.V. Co-therapy for the treatment of epilepsy
AU2009271362B2 (en) 2008-06-23 2014-03-13 Janssen Pharmaceutica Nv Crystalline form of (2s)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
CN103172583A (zh) * 2013-03-07 2013-06-26 深圳市资福药业有限公司 一种制备帕瑞昔布的方法
US10028904B2 (en) 2014-12-04 2018-07-24 Wisconsin Alumni Research Foundation Transdermal cannabinoid formulations
US9375417B2 (en) 2014-12-04 2016-06-28 Mary's Medicinals LLC Transdermal cannabinoid formulations
CN114441666B (zh) * 2020-11-05 2024-02-27 成都百裕制药股份有限公司 一种4-(5-甲基-3-苯基-4-异恶唑)苯磺酰氯中杂质的检测方法
WO2022195579A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5633272A (en) 1995-02-13 1997-05-27 Talley; John J. Substituted isoxazoles for the treatment of inflammation
JP3267300B2 (ja) * 1995-02-13 2002-03-18 ジー．ディー．サール アンド カンパニー 炎症の治療のための置換イソオキサゾール
US5643933A (en) 1995-06-02 1997-07-01 G. D. Searle & Co. Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
HUP0400923A3 (en) * 1996-08-14 2007-11-28 Searle & Co Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide, process for its preparation, its use and pharmaceutical compositions containing it
US7538126B2 (en) * 2003-04-04 2009-05-26 Hetero Drugs Limited Crystalline forms of valdecoxib
US20050272787A1 (en) * 2004-05-19 2005-12-08 Eswaraiah Sajja Process for preparing crystalline form A of valdecoxib

Also Published As

Publication number Publication date
IL161224A0 (en) 2004-09-27
CN1233243A (zh) 1999-10-27
NO990541D0 (no) 1999-02-05
KR20000029994A (ko) 2000-05-25
JP2000506542A (ja) 2000-05-30
TR199900298T2 (xx) 1999-05-21
CZ297679B6 (cs) 2007-03-07
ES2188971T3 (es) 2003-07-01
DE69717281D1 (de) 2003-01-02
SK13699A3 (en) 1999-07-12
AP1055A (en) 2002-04-04
JP3631763B2 (ja) 2005-03-23
DE69717281T2 (de) 2003-09-04
SI9720059A (sl) 1999-12-31
AU4093697A (en) 1998-03-06
NO312461B1 (no) 2002-05-13
UA52684C2 (uk) 2003-01-15
EE04237B1 (et) 2004-02-16
ATE228117T1 (de) 2002-12-15
NZ334132A (en) 2000-06-23
LV12274A (lv) 1999-05-20
SK283558B6 (sk) 2003-09-11
HUP0400923A2 (hu) 2004-08-30
EE9900053A (et) 1999-08-16
RO120771B1 (ro) 2006-07-28
EP0920422A1 (en) 1999-06-09
US20030004200A1 (en) 2003-01-02
EA199900200A1 (ru) 1999-06-24
PL191313B1 (pl) 2006-04-28
RS49671B (sr) 2007-11-15
AR009244A1 (es) 2000-04-12
US6441014B2 (en) 2002-08-27
GEP20022636B (en) 2002-02-25
EA001472B1 (ru) 2001-04-23
KR100383148B1 (ko) 2003-05-09
DK0920422T3 (da) 2003-03-17
AP9901458A0 (en) 1999-03-31
AU722072B2 (en) 2000-07-20
YU7499A (sh) 2000-03-21
IL128255A0 (en) 1999-11-30
LT4551B (lt) 1999-10-25
CN1205193C (zh) 2005-06-08
OA11298A (en) 2003-10-22
US20010003752A1 (en) 2001-06-14
WO1998006708A1 (en) 1998-02-19
BG103155A (en) 1999-11-30
EA200000891A1 (ru) 2001-02-26
SI9720059B (sl) 2011-11-30
IS4961A (is) 1999-01-29
PT920422E (pt) 2003-03-31
JP2005015497A (ja) 2005-01-20
EA003754B1 (ru) 2003-08-28
BR9711151A (pt) 1999-08-17
LV12274B (en) 1999-09-20
HUP0400923A3 (en) 2007-11-28
CA2264104A1 (en) 1998-02-19
ZA977314B (en) 1998-08-14
PL331607A1 (en) 1999-08-02
IS1989B (is) 2005-02-15
TW527350B (en) 2003-04-11
LT99024A (en) 1999-07-26
HK1023125A1 (en) 2000-09-01
IL128255A (en) 2004-06-20
EP0920422B1 (en) 2002-11-20
CZ33499A3 (cs) 1999-06-16
BG64259B1 (bg) 2004-07-30
EP1283203A1 (en) 2003-02-12
US7135489B2 (en) 2006-11-14

Similar Documents

Publication Publication Date Title
NO990541L (no) Krystallinsk form av 4-(5-metyl-3-fenylisoksazol-4-yl)benzensulfonamid
NO995852D0 (no) Ny form av S-omeprazol
ATE408607T1 (de) Substituierte benzensulfonamid-derivate als wirkstoff-vorläufer von cox-2 inhibitoren
DE69631100D1 (de) Ätzung von Nitridkristallen
DE19681287T1 (de) Orale Formulierung von 2-Methylthienobenzodiazepin
DK0946547T3 (da) Hidtil ukendt forbindelsesform
ID24481A (id) Gastrokinetik monosiklik benzamida dari derivat-3-atau-tersubstitusi 4-(aminometil)-piperidin
NO964950D0 (no) Krystallinsk hydroklorid av (R)-(-)-2-æN-[4-1,1-dioksido-3-okso-2,3-dihydrobenzisotiazol-2-yl)-butylÅ-aminometylå-chroman
NO20011083L (no) Krystallinske former av EtOC2--CH2-(R)Cgl-Aze-Pab-OH
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
DE69935165D1 (de) Herstellung von polyolefin
NO20010553D0 (no) Krystallinske former av osanetant
NO992268D0 (no) N-bundne sulfonamider av heterocykliske tioestere
NO983784L (no) Fremgangsmåter for fremstilling av bifenyl-isoksasolsulfonamider
NO20030658D0 (no) Modulering av multippel ''lineage'' kinaseproteiner
NO991148L (no) Fremstilling av 1-butyl-4-piperidinyl-metylamin
DK0858342T3 (da) Tørsammensætninger af ionofore antibiotika
EE200400073A (et) 4-(5-metüül-3-fenüülisoksasool-4-üül)benseensulfoonamiidi kristalliline vorm ja selle kasutamine
NO20004583D0 (no) Krystallinsk form av paroxetine
DK0810216T3 (da) Derivater af 10,11-dihydro-10-oxo-5H-dibenz/b/,f/azepin-5-carboxamid
NO20005856D0 (no) Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner
NO953272L (no) Kombinasjoner av retrovirale inhibitorer
SE9702853D0 (sv) Fasning av mynt
SE9600037D0 (sv) Modifiering av cement
FI3045U1 (fi) Säilytysrasiasarja